$41.18 0.00 (%) Mylan N.V. - NASDAQ

Sep. 26, 2016 | 04:00 PM

Partner Headlines

  1. Time For Congress To Stop Hollering At CEOs And Take Action

    TalkMarkets | Sep. 25, 2016 | 20:12PM EST
  2. Mylan - Should This Stock Be In Your Portfolio?

    TalkMarkets | Sep. 25, 2016 | 04:03AM EST
  3. Wells Fargo And Mylan: Corporate Devils Or Unworthy Scapegoats?

    TalkMarkets | Sep. 23, 2016 | 19:00PM EST
  4. Wells Fargo And Mylan: Corporate Devils Or Scapegoats?

    TalkMarkets | Sep. 23, 2016 | 19:00PM EST
  5. David Einhorn's Top 5 New Q4 Buys

    GuruFocus | Feb. 16, 2016 | 18:51PM EST
  6. Benzinga's M&A Chatter for Wednesday February 10, 2016

    Benzinga | Feb. 10, 2016 | 21:59PM EST
  7. Mylan Will Buy Meda For $9.9 Billion, Q4 Earnings Miss; Stock Dives

    IBD | Feb. 10, 2016 | 17:30PM EST
  8. David Einhorn Rebounds - Somewhat

    GuruFocus | Feb. 9, 2016 | 16:12PM EST
  9. David Einhorn Comments on Mylan

    GuruFocus | Jan. 19, 2016 | 17:32PM EST
  10. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD | Jan. 8, 2016 | 15:34PM EST
  11. Clinton To Target 'Inversions' With Exit Tax

    FoxBusiness | Dec. 9, 2015 | 14:41PM EST
  12. Pfizer-Allergan Won't Be the Last Inversion

    FoxBusiness | Nov. 23, 2015 | 12:26PM EST
  13. Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Health Care Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  14. Health Care Investor Larry Robbins Sells Drug Manufacturers, Buys Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
  15. Pfizer-Allergan A Go Despite New Tax Inversion Rules?

    IBD | Nov. 19, 2015 | 19:05PM EST
  16. Pfizer, Allergan Near Deal As Tax Inversion Rules Loom

    IBD | Nov. 18, 2015 | 22:38PM EST
  17. Treasury Plans New 'Targeted' Tax-Inversion Crackdown

    IBD | Nov. 18, 2015 | 18:05PM EST
  18. John Paulson Keeps Gold, Buys Drug Manufacturers in Q3

    GuruFocus | Nov. 17, 2015 | 13:13PM EST
  19. Benzinga's Weekend M&A Chatter

    Benzinga | Nov. 15, 2015 | 20:01PM EST
  20. Vanguard Raises Stakes in Biogen, Mylan, Merck

    GuruFocus | Nov. 15, 2015 | 13:10PM EST
  21. Mylan Finally Over Perrigo?

    IBD | Nov. 13, 2015 | 18:59PM EST
  22. Worst Performing Industries For November 13, 2015

    Benzinga | Nov. 13, 2015 | 12:28PM EST
  23. Major Averages Take More Heat; Retail Stocks Slammed On Weak Data

    IBD | Nov. 13, 2015 | 11:44AM EST
  24. Stocks Falter At Start Of Trade; Fossil, El Pollo, GameStop Slide

    IBD | Nov. 13, 2015 | 10:34AM EST
  25. Benzinga's Volume Movers

    Benzinga | Nov. 13, 2015 | 10:23AM EST
  26. Mylan Bid For Perrigo Fails On Shareholder Vote

    IBD | Nov. 13, 2015 | 09:58AM EST
  27. Stock Futures Dig Deeper; Perrigo, Nordstrom, Cisco Tumble

    IBD | Nov. 13, 2015 | 09:05AM EST
  28. Mylan To Lose Hostile Takeover Of Perrigo

    Benzinga | Nov. 13, 2015 | 09:03AM EST
  29. Benzinga's Top #PreMarket Losers

    Benzinga | Nov. 13, 2015 | 08:20AM EST
  30. Benzinga's Top #PreMarket Gainers

    Benzinga | Nov. 13, 2015 | 08:14AM EST
  31. Mylan, Perrigo bicker over bid

    IBD | Nov. 12, 2015 | 18:45PM EST
  32. Mylan, Perrigo Face Off As Takeover Vote Nears

    IBD | Nov. 12, 2015 | 12:18PM EST
  33. Perrigo Sends Letter to Holders, Discusses Mylan Deal; Says 'Corporate Governance, Mylan Style: A Question Of Trust

    Benzinga | Nov. 9, 2015 | 07:05AM EST
  34. Keeley Funds Comments on Mylan NV

    GuruFocus | Nov. 3, 2015 | 13:58PM EST
  35. Vanguard Health Care Fund Buys Biogen and Mylan, Cuts Pfizer

    GuruFocus | Nov. 2, 2015 | 12:33PM EST
  36. AbbVie, Mylan Profit Surprise

    IBD | Oct. 30, 2015 | 18:13PM EST
  37. Perrigo Continues to Oppose Mylan's Inadequate Offer

    Benzinga | Oct. 30, 2015 | 15:39PM EST
  38. Stocks Dip In Light Trade; LinkedIn Soars After Hours

    IBD | Oct. 29, 2015 | 17:18PM EST
  39. Tel Aviv District Court Rules in Favor of Mylan Listing on Tel Aviv Stock Exchange

    Benzinga | Oct. 28, 2015 | 15:15PM EST
  40. Gilead, Biotechs Were TPP Losers; Boeing Is Upbeat

    IBD | Oct. 6, 2015 | 13:37PM EST
  41. Valeant Defended After Politics-Induced Sell-Off

    IBD | Sep. 29, 2015 | 12:45PM EST
  42. Benzinga's Weekend M&A Chatter

    Benzinga | Sep. 27, 2015 | 18:53PM EST
  43. Benzinga's M&A Chatter for Thursday September 17, 2015

    Benzinga | Sep. 17, 2015 | 19:11PM EST
  44. Theravance Biopharma and Mylan Initiate Phase 3 Program for Revefenacin (TD-4208) for Treatment ...

    GuruFocus | Sep. 15, 2015 | 00:02AM EST
  45. Theravance Biopharma, Mylan Report Initiation of Phase 3 Program for Revefenacin for the Treatment of COPD

    Benzinga | Sep. 14, 2015 | 08:06AM EST
  46. Alan Fournier Sells Nine Stakes in Second Quarter

    GuruFocus | Sep. 12, 2015 | 22:49PM EST
  47. Benzinga's M&A Chatter for Tuesday September 8, 2015

    Benzinga | Sep. 8, 2015 | 21:02PM EST
  48. Benzinga's Weekend M&A Chatter

    Benzinga | Aug. 30, 2015 | 20:30PM EST
  49. Sequoia Fund Comments on Perrigo

    GuruFocus | Aug. 28, 2015 | 15:27PM EST
  50. Mylan Confirms USPTO Institutes Inter Partes Review Proceedings vs Two Copaxone 40 mg/mL Dosing Patents

    Benzinga | Aug. 25, 2015 | 15:05PM EST
Trading Center